Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 11641–11660 of 17,529 recalls

March 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 4 (Papaverine 18 mg

The Issue: Lack of Assurance of Sterility: incomplete or missing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Impax Laboratories, Inc.

Recalled Item: Dextroamphetamine Sulfate Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 0 (PGE 20 mcg/mL) Injection

The Issue: Lack of Assurance of Sterility: incomplete or missing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 3 (Papaverine 20 mg

The Issue: Stability Does Not Support Expiry: manufactured with an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 1 (Papaverine 1.8 mg

The Issue: Stability Does Not Support Expiry: manufactured with an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Impax Laboratories, Inc.

Recalled Item: Dextroamphetamine Sulfate Tablets USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 2 (Papaverine 9 mg

The Issue: Superpotent Drug: one ingredient was found to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 2 (Papaverine 9 mg

The Issue: Stability Does Not Support Expiry: manufactured with an

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 11, 2016· Jubilant Draximage Inc

Recalled Item: SODIUM IODIDE I 131 CAPSULE

The Issue: Labeling: Label Error on Declared Strength

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient

The Issue: CGMP Deviations: active pharmaceutical ingredient intermediates failed specifica

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
March 9, 2016· Teva Pharmaceuticals USA

Recalled Item: Amikacin Sulfate injection USP

The Issue: Presence of Particulate Matter: particulate matter identified as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 8, 2016· Hospira Inc.

Recalled Item: Dextrose Injection

The Issue: Chemical Contamination: Potential for contamination of the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 8, 2016· Hospira Inc.

Recalled Item: Mannitol I.V.

The Issue: Chemical Contamination: Potential for contamination of the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 8, 2016· Hospira Inc.

Recalled Item: Dextrose Injection

The Issue: Chemical Contamination: Potential for contamination of the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 8, 2016· Hospira Inc.

Recalled Item: Dextrose Injection

The Issue: Chemical Contamination: Potential for contamination of the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 8, 2016· Hospira Inc.

Recalled Item: Aminosyn-PF (amino acids) 7%

The Issue: Chemical Contamination: Potential for contamination of the products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund